UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Controlled Trial of Erenumab for Episodic Migraine

The New England journal of medicine, 2017-11, Vol.377 (22), p.2123-2132

2017

Volltextzugriff (PDF)

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

Cephalalgia, 2018-05, Vol.38 (6), p.1026-1037

2018

Volltextzugriff (PDF)

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Lancet neurology, 2014-02, Vol.13 (2), p.141-149

2014

Volltextzugriff (PDF)

Efficacy and safety evaluation of HSD-1 inhibitor ABT-384 in Alzheimer's disease

Alzheimer's & dementia, 2014-10, Vol.10 (5), p.S364-S373

2014

Volltextzugriff (PDF)

Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial

Neurology, 2019-05, Vol.92 (20), p.e2309

2019

Volltextzugriff (PDF)

A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina

Headache, 2018-05, Vol.58 (5), p.715-723

2018

Volltextzugriff (PDF)

Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study

Neurology, 2017-09, Vol.89 (12), p.1237-1243

2017

Volltextzugriff (PDF)

Treatment patterns and characteristics of patients with migraine in Japan: A retrospective analysis of health insurance claims data

Cephalalgia, 2019-10, Vol.39 (12), p.1518-1534

2019

Volltextzugriff (PDF)

Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States

Headache, 2017-10, Vol.57 (9), p.1399-1408

2017

Volltextzugriff (PDF)

One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study

Neurology, 2020-08, Vol.95 (5)

2020

Volltextzugriff (PDF)

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab

Cephalalgia, 2018-09, Vol.38 (10), p.1622-1631

2018

Volltextzugriff (PDF)

A Randomized Trial of the Efficacy and Safety of the H3 Antagonist ABT-288 in Cognitive Impairment Associated With Schizophrenia

Schizophrenia bulletin, 2014-11, Vol.40 (6), p.1433-1442

2014

Volltextzugriff (PDF)

The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response

Cephalalgia, 2020-01, Vol.40 (1), p.28-38

2020

Volltextzugriff (PDF)

The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response

Headache, 2020-10, Vol.60 (9), p.2026-2040

2020

Volltextzugriff (PDF)

A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia

Journal of Alzheimer's disease, 2014, Vol.42 (3), p.959

2014

Volltextzugriff (PDF)

Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results

Parkinsonism & related disorders, 2013-03, Vol.19 (3), p.339-345

2013

Volltextzugriff (PDF)

The scopolamine model as a pharmacodynamic marker in early drug development

Psychopharmacologia, 2012-03, Vol.220 (1), p.97-107

2012

Volltextzugriff (PDF)

ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

Alzheimer's research & therapy, 2016-10, Vol.8 (1), p.44-44, Article 44

2016

Volltextzugriff (PDF)

Divalproex Sodium in Children with Partial Seizures: 12-Month Safety Study

Pediatric neurology, 2009-08, Vol.41 (2), p.101-110

2009

Volltextzugriff (PDF)

Cerebrospinal Fluid Cytokine Dynamics Differ Between Alzheimer Disease Patients and Elderly Controls

Alzheimer disease and associated disorders, 2012-10, Vol.26 (4), p.322-328

2012

Volltextzugriff (PDF)

Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease

Alzheimer disease and associated disorders, 2015-07, Vol.29 (3), p.192-199

2015

Volltextzugriff (PDF)

Single- and Multiple-Dose Pharmacokinetics, Safety, and Tolerability of the Selective α7 Neuronal Nicotinic Receptor Agonist, ABT-107, in Healthy Human Volunteers

Journal of clinical pharmacology, 2011-04, Vol.51 (4), p.512-526

2011

Volltextzugriff (PDF)

Single- and Multiple-Dose Pharmacokinetics, Safety, and Tolerability of the Selective alpha 7 Neuronal Nicotinic Receptor Agonist, ABT-107, in Healthy Human Volunteers

Journal of clinical pharmacology, 2011-04, Vol.51 (4), p.512-526

2011

Volltextzugriff (PDF)

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia

Alzheimer's & dementia : translational research & clinical interventions, 2015-06, Vol.1 (1), p.81-90

2015

Volltextzugriff (PDF)

High Intracellular Cl- Concentrations Depress G-Protein-Modulated Ionic Conductances

The Journal of neuroscience, 1997-08, Vol.17 (16), p.6133-6141

1997

Volltextzugriff (PDF)

1 – 25 von 1.046

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(847)
Mit Volltextzugriff
(930)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(605)
Life Sciences & Biomedicine
(377)
Humans
(259)
Physical Sciences
(217)
Male
(175)
Female
(171)
Polymer Science
(165)
Middle Aged
(131)
Exact Sciences And Technology
(123)
Applied Sciences
(120)
Physicochemistry Of Polymers
(119)
Organic Polymers
(108)
Biological And Medical Sciences
(100)
Adult
(99)
Aged
(98)
Oncology
(82)
Medical Sciences
(69)
Animals
(67)
Preparation, Kinetics, Thermodynamics, Mechanism And Catalysts
(58)
Chemistry
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

A Controlled Trial of Erenumab for Episodic Migraine

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Efficacy and safety evaluation of HSD-1 inhibitor ABT-384 in Alzheimer's disease

Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial

A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina

Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study

Treatment patterns and characteristics of patients with migraine in Japan: A retrospective analysis of health insurance claims data

Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States

One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab

A Randomized Trial of the Efficacy and Safety of the H3 Antagonist ABT-288 in Cognitive Impairment Associated With Schizophrenia

The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response

The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response

A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia

Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results

The scopolamine model as a pharmacodynamic marker in early drug development

ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

Divalproex Sodium in Children with Partial Seizures: 12-Month Safety Study

Cerebrospinal Fluid Cytokine Dynamics Differ Between Alzheimer Disease Patients and Elderly Controls

Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease

Single- and Multiple-Dose Pharmacokinetics, Safety, and Tolerability of the Selective α7 Neuronal Nicotinic Receptor Agonist, ABT-107, in Healthy Human Volunteers

Single- and Multiple-Dose Pharmacokinetics, Safety, and Tolerability of the Selective alpha 7 Neuronal Nicotinic Receptor Agonist, ABT-107, in Healthy Human Volunteers

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia

High Intracellular Cl- Concentrations Depress G-Protein-Modulated Ionic Conductances

Suchergebnisse filtern